Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

XVOL vs. VPMCX: which is better?

Bottom line

XVOL vs VPMCX: the short answer

XVOL (Acruence Active Hedge U.S. Equity ETF) and VPMCX (Vanguard PRIMECAP Fund) are both etfs.

VPMCX is cheaper at 0.35% vs 0.83% — a difference of $48 a year per $10,000 invested.

Over one year, VPMCX returned +29.9% vs +19.9% for XVOL (reporting dates differ).

Updated Nov 19, 2026

XVOL vs VPMCX side by side

XVOLVPMCX
TypeETFMutual fund
Fund familyFranklin TempletonVanguard
CategoryLarge BlendLarge Blend
Expense ratio0.83%0.35%
Annual cost per $10k$83$35
10-yr cost on $10k (prospectus)$1,025$443
Max front loadNone0%
12b-1 fee0%0%
1-yr return+19.9%+29.9%
5-yr return (annualized)—+14.3%
10-yr return (annualized)—+15.2%
Best quarter+13.1%+17.3%
Worst quarter−16.5%−20.2%
Net assets (fund)—$96.1B
Number of holdings—173
Portfolio turnover361%11%
Returns as ofDec 31, 2024Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearXVOLVPMCXDifference
2024+19.9%+13.5%+6.5%
2023+7.3%+28.1%−20.8%
2022−20.9%−15.2%−5.8%

Source: Fund prospectus bar charts

Holdings overlap

XVOL and VPMCX share none of their top holdings.

XVOL top 10

    VPMCX top 10

    1. Micron Technology Inc — 13.50%
    2. Intel Corp — 6.80%
    3. Eli Lilly & Co — 6.76%
    4. KLA Corp — 3.85%
    5. Alphabet Inc — 3.52%
    6. AstraZeneca PLC — 2.35%
    7. NVIDIA Corp — 2.33%
    8. Amazon.com Inc — 2.05%
    9. Tesla Inc — 1.89%
    10. Biogen Inc — 1.88%

    FAQ

    What is the difference between XVOL and VPMCX?
    XVOL (Acruence Active Hedge U.S. Equity ETF) and VPMCX (Vanguard PRIMECAP Fund) are both etfs. VPMCX is cheaper at 0.35% vs 0.83% — a difference of $48 a year per $10,000 invested.
    Which is cheaper, XVOL or VPMCX?
    VPMCX has the lower expense ratio (0.35%).
    Should I own both XVOL and VPMCX?
    Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

    Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.